The latest closing stock price for Avenue Therapeutics as of November 22, 2024 is 2.01.
An investor who bought $1,000 worth of Avenue Therapeutics stock at the IPO in 2017 would have $-1,000 today, roughly -1 times their original investment - a -70.04% compound annual growth rate over 7 years.
The all-time high Avenue Therapeutics stock closing price was 13567.50 on September 14, 2020.
The Avenue Therapeutics 52-week high stock price is 26.53, which is 1219.9% above the current share price.
The Avenue Therapeutics 52-week low stock price is 1.60, which is 20.4% below the current share price.
The average Avenue Therapeutics stock price for the last 52 weeks is 6.57.
An investor who bought $1,000 worth of Avenue Therapeutics stock at the IPO in 2017 would have $-1,000 today, roughly -1 times their original investment - a -70.04% compound annual growth rate over 7 years.
The all-time high Avenue Therapeutics stock closing price was 13567.50 on September 14, 2020.
The Avenue Therapeutics 52-week high stock price is 26.53, which is 1219.9% above the current share price.
The Avenue Therapeutics 52-week low stock price is 1.60, which is 20.4% below the current share price.
The average Avenue Therapeutics stock price for the last 52 weeks is 6.57.